6th International Conference Neonatal and Childhood Pulmonary Vascular Disease

Register

UCSF Continuing Medical Education has transitioned to a new online registration system.

You will be prompted to login to your account using your email address in order to register for this course.
If you have registered for a UCSF CME course in the past, you are already in our system and should have received an email with detailed instructions on how to login.

If this is your first course with UCSF CME, please create a new account.

 


ABSTRACT SUBMISSION INSTRUCTIONS


Overview Objectives
Accreditation Course Outline
Chairs Faculty
Travel & Lodging Cancellation Policy


Department: Pediatrics
Course Number: MPD13002
Start: Friday, June 21, 2013
End: Saturday, June 22, 2013
Location: San Francisco, California
Hilton Financial District San Francisco
Fees:

$525 - Practicing Physicians
$425 - Allied Health Professionals
$200 - Residents/Fellows
$425 - Members of Pediatric Cardiac ICU Society
$150 - UCSF Allied Health Professionals
$10 - Patients/Family/Caregivers

SINGLE DAY RATES:
Either Friday 6/21/13 or Saturday 6/22/13 Only
$275 - Practicing Physicians
$225 - Allied Health Professionals
$100 - Residents/Fellows
$225 - Members of Pediatric Cardiac ICU Society
$75 - UCSF Allied Health Professionals
$10 - Patients/Family/Caregivers

CONCURRENT WORKSHOPS:
June 22, 2013 from 1:30 to 2:45pm

5A: Original Research - Abstracts, Posters, and Presentations
5B: Family Session - Special Issues Faced By Families Living with Pulmonary Hypertension

UCSF Association of Clinical Faculty Vouchers are accepted for this course. For more information please call the Office of Continuing Medical Education at 415-476-4251.
Credit:


Overview:

Over the past decade, great strides have been made in our understanding of the pathobiology of pulmonary vascular disease, and from these findings new therapeutic options have emerged. It is increasingly clear that pulmonary vascular pathology is integral to a number of childhood disorders. In this symposium, we will bring together international experts to explore our current understanding of the basic pathobiology as well as new and future therapies for neonatal, pediatric, and adult pulmonary vascular diseases.

TARGET AUDIENCE
Pediatric and Adult Pulmonologists, Cardiology and Critical Care Physicians, Neonatology Physicians, and Advanced Practice Nurses.

Back To Top


Objectives:

The purpose of this course is to increase competence and improve clinician practice in childhood pulmonary vascular disease. We specifically anticipate improvements in skills and strategies to:

  • apply new knowledge of the developmental vascular biology of neonatal pulmonary vascular disease to increase early detection of the pathology in infants;
  • discuss nursing aspects particular to the care of neonates, infants, and children with pulmonary vascular disease;
  • recognize the importance and potential treatment of pulmonary vascular disease in single ventricular physiology;
  • understand the advances in imaging and physiologic assessment of the pulmonary vasculature;
  • diagnosis and treatment of unusual forms of neonatal and childhood pulmonary vascular disease;
  • utilize established and emerging therapies for neonatal and childhood pulmonary vascular disease and assess the complex pharmacology of selected therapies;
  • implement family centered care for neonates and children with pulmonary hypertensive vascular disease.

Back To Top


Accreditation:

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 17.50 AMA PRA Category 1 CreditsTM.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements under California Assembly Bill 1195, Continuing Education and Cultural and Linguistic Competency.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.

Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 CreditTM.

Family Physicians This live activity, Neonatal and Childhood Pulmonary Vascular Disease, from June 21-22, 2013, has been reviewed and is acceptable for up to 18.50 Prescribed credit(s) by the American Academy of Family Physicians.

Since some sessions run concurrently, no more than [#] credits may be reported. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back To Top


Course Outline:

 

 

 

FRIDAY, JUNE 21, 2013

7:00 am Registration and Continental Breakfast

7:45 Welcome and Opening Remarks

 

SESSION 1: Neonatal Lung Disease and Pulmonary Vascular Alterations
MODERATORS: Dr. Roberta Keller and Dr. Bernard Thebaud

8:00 Systemic Vascular Changes Following Neonatal Hyperoxia Exposure
Dr. Anne Monique Nuyt

8:30 Intracellular Signaling in the Development of Bronchopulmonary Dysplasia
Dr. Jesse Roberts Jr.

9:00 Pulmonary Vascular Consequences of Bronchopulmonary Dysplasia
Dr. Peter Mourani

9:30 Long-term Consequences of Bronchopulmonary Dysplasia
Dr. Sharon McGrath-Morrow

10:00 Break

 

SESSION 2: Pulmonary Vascular Disease: Advanced Nursing Perspectives
MODERATORS: Beth Coleman, PNP and Emma Olson, PNP

10:30 Building a Successful Pediatric Pulmonary Hypertension Program
Patricia Lawrence, PNP

11:00 Practical Aspects of Invasive Therapies
Daniela Brady, RN
Michelle Calderbank, PNP

11:30 Successful Transition of the Late Adolescent PH Patient: US vs. Canada Transition Programs
Janette Reyes, NP, MS
Beth Coleman, PNP

12:00 Trisomy 21: Care for the Patient and Family
Sue Robins

12:30 Lunch on your own

 

SESSION 3: Stem Cell Therapies in PH
MODERATORS: Dr. Tilman Humpl and Dr. Stephen Archer

1:30 Stem Cells in Neonatal Pulmonary Hypertensive Vascular Disease
Dr. Stella Kourembanas

2:00 Current Status of Stem Cell Therapy in Pulmonary Hypertensive Vascular Disease
Dr. Duncan Stewart

2:30 Role of the Large Vessels in the Distal Vascular Abnormalities That Characterize Pulmonary Hypertension
Dr. Kurt Stenmark

 

SESSION 4: Pulmonary Vasculature in Single Ventricular Physiology
MODERATORS: Dr. Thomas Kulik and Dr. Peter Oishi

3:00 Pitfalls in Pulmonary Vascular Resistance Determinations in Single Ventricular Physiology
Dr. Sohrab Fratz

3:30 Ventricular-Pulmonary Vascular Coupling after the Total Cavopulmonary
Anastomosis (Fontan)
Dr. Andrew Redington

4:00 Break

4:15 The Role of Pulmonary Hypertensive Therapy in SV Physiology
Dr. Brian Hanna

4:45 World Symposium on Pulmonary Hypertension Pediatric Pulmonary Hypertension Guidelines
Dr. Steven Abman

The Sildenafil Controversy

5:15 Introduction and Data Presentation
Dr. Dunbar Ivy

FDA Perspective
Dr. Norman Stockbridge

European Medicines Agency Perspective
Dr. Birka Lehmann

Open Discussion

6:15 Adjourn

 

 

 

SATURDAY, JUNE 22, 2013

7:15 am Continental Breakfast

7:45 The Robyn Barst Keynote Lecture – Introduction Dr. Erika Berman Rosenzweig

8:00 KEYNOTE SPEAKER: Dr. Nazzareno Galié
Is Shunt Closure the Best Decision? Long-term Outcomes of Pulmonary Hypertensive Vascular Disease Associated with Congenital Heart Disease

 

SESSION 5: Targeted Therapies in Children with Pulmonary Hypertensive Vascular Disease
MODERATORS: Dr. John Kinsella and Dr. Steven Abman

8:45 Inhaled Treatments
Dr. Dunbar Ivy

9:15 Intravenous Treatments
Dr. Erika Berman Rosenzweig

9:45 Oral Treatments
Dr. Mary Mullen

10:15 Subcutaneous Treatments
Dr. Maria del Cerro

10:45 Break

11:15 When to Evaluate and List Children with Pulmonary
Hypertensive Vascular Disease for Lung Transplantation
Dr. George Mallory

11:45 Mechanical Support of the Right Ventricle in Children
with Pulmonary Hypertensive Vascular Disease
Dr. Ivan Rebeyka

12:15pm Assessing Therapies in Rare Diseases
Dr. Thomas MacDonald

12:45 Paediatric Formulations, Pharmaceutical Excipients, and Drug Delivery Devices
Dr. Jorg Breitkreutz

1:15-2:15 Lunch on own

 

SESSION 6: CONCURRENT SESSIONS

2:15-3:30 Original Research – Abstracts, Posters, and Presentations
MODERATORS: Dr. Usha Raj and Dr. Stephen Archer

2:15-5:45 Family Session – Special Issues Faced By Families
Living with Pulmonary Hypertension
MODERATOR: Jennifer Gendron

Panel – Steve van Wormer, Los Angeles, California;
Sarah Platnar, Ontario, Canada; Janie Kidd, Ontario, Canada

 

SESSION 7: Assessment of the Pulmonary Vasculature
MODERATORS: Dr. Usha Krishnan and Dr. Robin Steinhorn

3:30 Integration of Cardiac Catheterization and MRI Diagnosis,
Reactivity Testing and Disease Progression in Children with Pulmonary Vascular Disease
Dr. Shahin Moledina

4:00 Echocardiographic Assessment of Right Ventricle Function and Failure in Children with Pulmonary Hypertension
Dr. Mark Friedberg

4:30 Break

4:45 Non-Invasive Risk Predictors in Children with Pulmonary Hypertension
Dr. Gerhard-Paul Diller

5:15 The Pulmonary Vasculature and Assessment of Right Ventricular Afterload
Dr. Ryan Tedford

5:45 Pulmonary Arterio-Venous Malformations: Diagnosis and Etiology
Dr. Julien Hoffman

6:15 Closing Remarks

6:30 pm Adjourn

Back To Top


Chairs:

Ian Adatia, MBChB
Professor of Pediatrics, University of Alberta; Director, Pediatric Cardiac Critical and Intermediate Care Program; Director, Pediatric Pulmonary Hypertension Clinic, Stollery Children's Hospital, Edmonton, AB, Canada

Jeffrey Fineman, MD
Professor of Pediatrics; Investigator, Cardiovascular Research Institute, UCSF Children's Hospital, San Francisco, CA, USA

Back To Top


Faculty:

Steven Abman, MD
Professor of Pediatrics, Director of Pediatric Heart-Lung Center, University of Colorado, Denver, CO, USA

Stephen L. Archer, MD
Harold Hines Jr. Professor of Medicine; Chief, Cardiology University of Chicago, Chicago, IL, USA

Erika Berman Rosenzweig, MD
Associate Professor of Pediatrics (in Medicine), Columbia University, College of Physicians and Surgeons; Director, Pulmonary Hypertension Center, New York, NY, USA

Daniela Brady, RN
Research Nurse Clinician, Pulmonary Hypertension Center, Columbia University Medical Center, New York, NY, USA

Beth Coleman, RN, MSN, CPNP
Pediatric Nurse Practitioner, Pulmonary Hypertension Program, Children’s Hospital Colorado, Aurora, CO, USA

Maria Jesus del Cerro, MD
Pediatric Pulmonary Hypertension Unit; Pediatric Cardiology, "La Paz" Hospital, Madrid, Spain

Gerhard-Paul Diller MD PhD MSc FESC
Consultant Cardiologist, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital of Münster, Germany

Sohrab Fratz, MD, PhD, FESC
Head of Cardiovascular Magnetic Resonance, Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München (German Heart Center), Munich, Germany

Mark Friedberg , MD, FASE
Associate Professor of Pediatrics, University of Toronto, Staff Cardiologist, Hospital for Sick Children, Toronto, ON, Canada

Nazzareno Galié, MD
Associate Professor of Cardiology, University of Bologna, Italy

Jennifer Gendron
Regional Coordinator, Pulmonary Hypertension Association, Saint John, NB, Canada

Brian Hanna, MD, PhD
Clinical Associate Professor of Pediatrics, University of Pennsylvania, School of Medicine; Director, Pulmonary Hypertension, The Cardiac Center, Children's Hospital of Philadelphia, PA, USA

Julien Hoffman, MD
Professor of Pediatrics Emeritus, University of California, San Francisco, CA, USA

Tilman Humpl, MD, PhD
Assistant Professor of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

Dunbar Ivy, MD
Professor of Pediatrics; Chief and Selby's Chair of Pediatric Cardiology, University of Colorado, Denver, CO, USA

Roberta L. Keller, MD
Associate Professor of Clinical Pediatrics; Director, Neonatal ECMO Program; Director of Neonatal Services, Fetal Treatment Center, University of California San Francisco, UCSF Benioff Children's Hospital, San Francisco, CA, USA

Janie Kidd
Parent Caregiver, Holland Landing, ON, Canada

John P. Kinsella, MD
Professor of Pediatrics; University of Colorado and the Children's Hospital, Denver; Medical Director, Newborn Transport Service; Medical Director, Newborn ECMO Service, Denver, CO, USA

Stella Kourembanas, MD
Clement A. Smith Professor of Pediatrics, Harvard Medical School of Medicine, Cambridge, MA, USA

Usha Krishnan, MD
Associate Professor, Pediatrics (Cardiology), Associate Director, Pulmonary Hypertension Center, Columbia University Medical Center, New York, NY, USA

Thomas Kulik, MD
Senior Associate in Cardiology, Department of Cardiology, Children's Hospital Boston, Boston, MA, USA

Patricia R. Lawrence, PNP
Clinical Program Manager, Pulmonary Hypertension Program, Children's Healthcare of Atlanta, GA, USA


Birka Lehmann, MD
Director and Professor; Head EU and International Affairs, Federal Institute for Drugs and Medical Devices, Bonn, Germany

Thomas MacDonald, MD
Professor of Clinical Pharmacology and Pharmacoepidemiology, Medicines Monitoring Unit and Hypertension Research Centre, Ninewells Hospital & Medical School, Dundee, United Kingdom

George Mallory, MD
Professor of Pediatrics, Texas Children’s Hospital, Houston, TX, USA

Sharon McGrath-Morrow, MD, MBA
Associate Professor of Pediatrics, Division of Pediatric Pulmonary; Fellowship Director of Pediatric Pulmonary, Johns Hopkins School of Medicine, Baltimore, MD, USA

Shahin Moledina, MD
Lead Clinician, United Kingdom Pulmonary Hypertension Service, London, United Kingdom

Peter Mourani, MD
Associate Professor of Pediatrics; Director of Clinical Research, Section of Critical Care, University of Colorado School of Medicine, Aurora, CO, USA

Mary Mullen, MD, PhD
Associate in Cardiology, Children's Hospital, Boston, MA, USA

Anne Monique Nuyt, MD
Professor, Department of Medicine, Neonatology Service; University of Montreal, QB, Canada

Peter E. Oishi, MD
Assistant Professor, Pediatric Critical Care, University of California, San Francisco, CA, USA

Emma Olson, RN, MS, CPNP
UCSF Benioff Children’s Hospital, Pediatric Pulmonary Hypertension and Heart Failure, University of California, San Francisco, CA, USA

Sarah Platnar
Parent Caregiver, Pickering, ON, Canada

Usha Raj, MD
Professor and Head, Department of Pediatrics, University of Illinois, Chicago, IL, USA

Ivan Rebeyka, MD
Head, Pediatric Cardiac Surgery, University of Alberta Hospital, Edmonton, AB, Canada

Andrew N. Redington, MD
Division Head, Cardiology, The Hospital for Sick Children; Professor of Paediatrics, University of Toronto, Ontario, Canada

Janette Reyes, NP
Nurse Practitioner, Pulmonary Hypertension Service, The Labatt Family Heart Centre, The Hospital for Sick Children; Cross Appointment, Faculty of Nursing, University of Toronto, Toronto, ON, Canada

Jesse Roberts Jr., MD
Associate Professor, Harvard University Medical Center, Cambridge, MA, USA

Sue Robins
Family Centered Care Consultant, Edmonton, AB, Canada

Robin H. Steinhorn, MD
Professor and Chair, Department of Pediatrics, Physician in Chief, University of California, Davis Children's Hospital, Sacramento, CA, USA

Kurt Stenmark, MD
Professor of Pediatrics; Head, Pediatric Critical Care Medicine and Developmental Lung Biology Laboratory; Director, Cardiovascular Pulmonary Research Laboratory, University of Colorado,
Denver, CO, USA

Ryan J. Tedford, MD
Assistant Professor of Medicine, Heart Failure, Mechanical Circulatory Support and Cardiac Transplantation, Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA

Bernard Thébaud, MD
Professor of Pediatrics, University of Ottawa; Senior Scientist, Ottawa Hospital Research Institute
Neonatologist, Children’s Hospital of Eastern Ontario, Canada

Steve van Wormer
Pulmonary Hypertension Association Board Member, Pediatric Pulmonary Hypertension Parent Caregiver, Burbank, CA, USA

Andrew N. Redington, MD
Division Head, Cardiology, The Hospital for Sick Children; Professor of Paediatrics, University of Toronto, Ontario, Canada

Janette Reyes, NP
Nurse Practitioner, Pulmonary Hypertension Service, The Labatt Family Heart Centre, The Hospital for Sick Children; Cross Appointment, Faculty of Nursing, University of Toronto, Toronto, ON, Canada

Stuart Rich, MD
Professor of Medicine, Section of Cardiology, Center for Pulmonary Hypertension, University of Chicago, Chicago, IL, USA

Greg Ryan, MB
Professor, Departments of Obstetrics & Gynaecology (Division of Maternal-Fetal Medicine) and Medical Imaging, University of Toronto; Director, Fetal Medicine Program, Mount Sinai Hospital, Toronto, ON, Canada

Ingram Schulze-Neick, MD, PhD
Director, UK Service for Pulmonary Hypertension in Children, Cardiac Unit; Great Ormond Street Hospital, London, UK

Lara Shekerdemian, MD
Professor of Pediatrics, Baylor College of Medicine; Section Head, Pediatric Critical Care, Texas Children's Hospital, Houston, TX, USA

Robin H. Steinhorn, MD
Professor of Pediatrics; Chief of Neonatology, Northwestern University School of Medicine, Chicago, IL, USA

Kurt Stenmark, MD
Professor of Pediatrics; Head, Pediatric Critical Care Medicine and Developmental Lung Biology Laboratory; Director, Cardiovascular Pulmonary Research Laboratory, University of Colorado,
Denver, CO, USA

Bernard Thébaud, MD
Associate Professor, Department of Pediatrics, University of Alberta, Edmonton, AB, Canada

Rubin Tuder, MD
Hart Family Professor of Medicine and Pathology; Director, Program in Translational Lung Research, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Colorado
Health Sciences Center, Denver, CO, USA

David L. Wessel, MD
Executive Director, Center for Hospital-Based Specialties, Children's National Medical Center, Washington DC, USA

Back To Top


Travel & Lodging:

Hilton Financial District
750 Kearny Street
San Francisco, CA 94108
Hotel: 415-433-6600
http://www.sanfranciscohiltonhotel.com/
Reservations: 800-424-8292

Hotel Rates: $229/night
Cutoff Date: 5/30/13

Back To Top


Cancellation Policy:
Cancellations received in writing before the first day of the course will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date.

Back To Top